Health Catalyst files resale of 25,795 restricted shares

Health Catalyst, Inc. (restricted shares reported for sale) The filing reports a proposed resale of 25,795 restricted shares to be sold through Morgan Stanley Smith Barney LLC on 03/02/2026.

Rhea-AI Filing Summary

Health Catalyst, Inc. (restricted shares reported for sale)

The filing reports a proposed resale of 25,795 restricted shares to be sold through Morgan Stanley Smith Barney LLC on 03/02/2026. The filing also documents prior restricted-share dispositions by Daniel Burton: 55,715 shares on 12/01/2025 and 28,875 shares on 02/26/2026. Shares outstanding were 70,730,884 as of 03/02/2026.

Insights

Securities Compliance Analyst

Form 144 shows a planned resale of restricted stock and recent insider dispositions.

The filing lists a proposed sale of 25,795 restricted shares through Morgan Stanley Smith Barney LLC on 03/02/2026. It also records prior restricted-stock sales by Daniel Burton: 55,715 shares on 12/01/2025 for $161,584.64 and 28,875 shares on 02/26/2026 for $50,467.73.

Cash treatment and exact purchasers are not stated; timing and execution depend on broker handling and applicable resale conditions. Subsequent filings or transaction confirmations may report completion details and final proceeds.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the HCAT Form 144 disclose about shares to be sold?

The filing discloses a proposed resale of 25,795 restricted shares to be sold through Morgan Stanley on 03/02/2026. It lists the broker and the security type as restricted stock.

Who reported recent restricted-stock sales in the HCAT filing?

The filing shows restricted-stock dispositions by Daniel Burton: 55,715 shares on 12/01/2025 and 28,875 shares on 02/26/2026, with aggregate amounts reported in the excerpt.

How many shares outstanding does the HCAT filing show?

The excerpt cites total shares outstanding as 70,730,884 as of 03/02/2026. This figure is presented in the filing content as a context number tied to that date.

Which broker is handling the proposed HCAT resale?

The proposed resale is listed as to be handled by Morgan Stanley Smith Barney LLC, with the broker address shown as 1 New York Plaza, 38th Floor, New York, NY.

Are proceeds or purchasers identified in the HCAT Form 144?

The excerpt provides dollar figures associated with past restricted-share sales but does not identify final purchasers; the proposed sale lists the broker and quantity only, without purchaser names.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 07:16 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001780980
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Health Catalyst, Inc.
SEC File Number	001-38993
Address of Issuer	10897 S River Front Pkwy #300 South Jordan UTAH 84095
Phone	8553096800
Name of Person for Whose Account the Securities are To Be Sold	Daniel Burton
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Other

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	25795	42817.12	70730884	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/02/2026	Restricted Stock	Health Catalyst, Inc.			25795	03/02/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Daniel Burton c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	12/01/2025	55715	161584.64
Daniel Burton c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	02/26/2026	28875	50467.73

144: Remarks and Signature

Remarks
Date of Notice	03/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Daniel Burton
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)